Ahmed Marawan Shabana
Affiliations: | 2013-2018 | Pharmaceutical Sciences | Temple University, Philadelphia, PA, United States |
Google:
"Ahmed Shabana"Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Sufian MA, Zamanova S, Shabana AM, et al. (2023) Expression Dynamics of CA IX Epitope in Cancer Cells under Intermittent Hypoxia Correlates with Extracellular pH Drop and Cell Killing by Ureido-Sulfonamide CA IX Inhibitors. International Journal of Molecular Sciences. 24 |
| Mondal UK, Doroba K, Shabana AM, et al. (2021) PEG Linker Length Strongly Affects Tumor Cell Killing by PEGylated Carbonic Anhydrase Inhibitors in Hypoxic Carcinomas Expressing Carbonic Anhydrase IX. International Journal of Molecular Sciences. 22 |
| Zamanova S, Shabana AM, Mondal UK, et al. (2019) Carbonic anhydrases as disease markers. Expert Opinion On Therapeutic Patents |
| Shabana AM, Mondal UK, Alam MR, et al. (2018) pH-Sensitive Multi-ligand Gold Nanoplatform Targeting Carbonic Anhydrase IX Enhances the Delivery of Doxorubicin to Hypoxic Tumor Spheroids and Overcomes the Hypoxia-Induced Chemoresistance. Acs Applied Materials & Interfaces |
| Akocak S, Alam MR, Shabana AM, et al. (2016) PEGylated bis-sulfonamide carbonic anhydrase inhibitors can efficiently control the growth of several carbonic anhydrase IX-expressing carcinomas. Journal of Medicinal Chemistry |